MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41391-025-01032-0

Медицинская библиотека · Prostate cancer and prostatic diseases · 2025

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Rosato Rosalba, De Luca Stefano, Zitella Andrea, Munoz Fernando, Baima Carlo Giuliano, Barale Maurizio, Bardari Franco, Beldì Debora, Bellei Luca, Bellissimo Andrea Rocco, Bernardi Diego, Biamino Giorgio, Billia Michele, Borsa Roberto, Cante Domenico, Castelli Emanuele, Centrella Danilo, Checcucci Enrico, Collura Devis, Coppola Pietro, Dalmasso Ettore, Di Stasio Andrea, Fiorio Michele, Gatti Marco, Garibaldi Elisabetta, Girelli Giuseppe, Griffa Daniele, Guarneri Alessia, Guercio Stefano, Iorio Carlo Giuseppe, Migliari Roberto, Montefiore Franco, Moroni Maurizio, Muto Giovanni, Oderda Marco, Pagano Eva, Pasquale Massimo, Ponti di Sant'Angelo Francesca, Rossi Riccardo, Ruggiero Luca, Sedigh Omid, Serao Armando, Squeo Maria Sara, Stancati Salvatore, Varvello Francesco, Volpe Alessandro, Zaramella Stefano, Zarrelli Giovanni, Bollito Enrico, Gontero Paolo, Porpiglia Francesco, Galassi Claudia, Ciccone Giovannino, START Collaborative Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Real-world evidence on quality of life (QoL) changes associated with treatment decisions is crucial for informed choices by patients with low-risk prostate cancer (LRPC).

METHODS

A prospective cohort study was conducted in the Piemonte and Valle d'Aosta Regional Oncology Network, NW Italy (4.5 million population), including nearly all urology (N = 22) and radiation oncology (N = 6) centres. Patients newly diagnosed with LRPC, eligible for radical treatments, received balanced information on risks and benefits of available options and could choose among active surveillance (AS), radical prostatectomy (RP), or radiotherapy (RT). Longitudinal changes in QoL were assessed via patient-reported outcomes in four domains: general QoL, mental health, sexual function and urinary/bowel symptoms. The main comparison was between AS and RP. A secondary comparison was between AS and all radical treatments (RP or RT). Data were analysed by multivariable generalised linear or logistic models, following the intention-to-treat principle and accounting for correlation within centres and subjects.

RESULTS

A total of 651 patients (76.4% of those enrolled, 559 in AS, 76 in RP and 16 in RT) with baseline questionnaires were included (median [IQR] age, 70 [64-74] years). During a median follow-up of 37 months, no differences in general QoL or mental health were observed between AS and RP. Men in AS had better scores for sexual function (β = 8.27, 95% CI: 5.57-10.96) and activity (β = 6.70, 95% CI: 4.19-9.20). Use of incontinence aids was significantly lower in the AS group (OR = 0.14; 95% CI: 0.09-0.23). Prostatic obstructive symptoms remained stable in AS but decreased in the RP group (OR = 2.77; 95% CI: 1.52-5.06). Results were similar comparing AS to RP or RT.

CONCLUSIONS

Compared to radical prostatectomy, AS preserved urinary continence and sexual function but was associated with persistent obstructive symptoms, without differences in general QoL or mental health. This real-world study supports existing evidence, aiding LRPC patients in making informed decisions.

Для цитирования: Rosato Rosalba, De Luca Stefano, Zitella Andrea, Munoz Fernando, Baima Carlo Giuliano, Barale Maurizio, Bardari Franco, Beldì Debora, Bellei Luca, Bellissimo Andrea Rocco, Bernardi Diego, Biamino Giorgio, Billia Michele, Borsa Roberto, Cante Domenico, Castelli Emanuele, Centrella Danilo, Checcucci Enrico, Collura Devis, Coppola Pietro, Dalmasso Ettore, Di Stasio Andrea, Fiorio Michele, Gatti Marco, Garibaldi Elisabetta, Girelli Giuseppe, Griffa Daniele, Guarneri Alessia, Guercio Stefano, Iorio Carlo Giuseppe, Migliari Roberto, Montefiore Franco, Moroni Maurizio, Muto Giovanni, Oderda Marco, Pagano Eva, Pasquale Massimo, Ponti di Sant'Angelo Francesca, Rossi Riccardo, Ruggiero Luca, Sedigh Omid, Serao Armando, Squeo Maria Sara, Stancati Salvatore, Varvello Francesco, Volpe Alessandro, Zaramella Stefano, Zarrelli Giovanni, Bollito Enrico, Gontero Paolo, Porpiglia Francesco, Galassi Claudia, Ciccone Giovannino, START Collaborative Group. Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.. Prostate cancer and prostatic diseases. 2025. DOI: 10.1038/s41391-025-01032-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.